Skip to main content

Table 3 Response rates of primary chemotherapy for clear cell carcinoma

From: Clear cell carcinoma of the ovary: Is there a role of histology-specific treatment?

regimen author year response/ Number of patients, response rate
Conventional Platinum-based Goff [28] 1996 1/6, 17%
Sugiyama [29] 2000 3/27, 11%
Ho [30] 2004 4/15, 27%
Takano [9] 2006 5/30, 17%
Taxane-Platinum Enomoto [31] 2003 2/9, 22%
Ho [30] 2004 9/16, 56%
Utsunomiya [32] 2006 8/15, 53%
Takano [9] 2006 9/28, 32%
Irinotecan-cisplatin Takano [9] 2006 3/10, 30%